Tarsus Pharmaceuticals, Inc. financial data

Symbol
TARS on Nasdaq
Location
15440 Laguna Canyon Road, Irvine, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 485 % -27.5%
Quick Ratio 3.48 % -43.6%
Debt-to-equity 54.5 % +29.1%
Return On Equity -26.3 % +52.9%
Return On Assets -17 % +56.7%
Operating Margin -23.9 % +78%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42.4M shares +11%
Common Stock, Shares, Outstanding 42.4M shares +11.1%
Entity Public Float 996M USD +117%
Common Stock, Value, Issued 6K USD 0%
Weighted Average Number of Shares Outstanding, Basic 42.6M shares +11%
Weighted Average Number of Shares Outstanding, Diluted 42.6M shares +11%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 366M USD +182%
Research and Development Expense 63.2M USD +26.8%
General and Administrative Expense 57.9M USD +91%
Costs and Expenses 454M USD +67.8%
Operating Income (Loss) -87.4M USD +37.8%
Nonoperating Income (Expense) 6.26M USD +0.02%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -81.2M USD +39.6%
Earnings Per Share, Basic -1 USD/shares +47.5%
Earnings Per Share, Diluted -1 USD/shares +47.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 113M USD -36%
Marketable Securities, Current 289M USD +105%
Accounts Receivable, after Allowance for Credit Loss, Current 72.6M USD +149%
Inventory, Net 3.84M USD +34.8%
Assets, Current 502M USD +40.5%
Property, Plant and Equipment, Net 5.75M USD +140%
Operating Lease, Right-of-Use Asset 10.2M USD +468%
Intangible Assets, Net (Excluding Goodwill) 7.61M USD -11.2%
Other Assets, Noncurrent 1.18M USD +32.5%
Assets 535M USD +42.1%
Employee-related Liabilities, Current 13.6M USD +19.7%
Liabilities, Current 117M USD +77.7%
Operating Lease, Liability, Noncurrent 10.1M USD +718%
Other Liabilities, Noncurrent 10.1M USD +718%
Liabilities 199M USD +43.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 289K USD -16.5%
Retained Earnings (Accumulated Deficit) -418M USD -24.1%
Stockholders' Equity Attributable to Parent 335M USD +41.1%
Liabilities and Equity 535M USD +42.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.7M USD +45.4%
Net Cash Provided by (Used in) Financing Activities 137M USD +25.6%
Net Cash Provided by (Used in) Investing Activities -34.9M USD +65.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 42.4M shares +11.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 81M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 115M USD -34.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.07M USD +139%
Deferred Tax Assets, Valuation Allowance 88M USD +46.1%
Deferred Tax Assets, Gross 88.4M USD +44.9%
Operating Lease, Liability 10.2M USD +446%
Depreciation 835K USD +17.6%
Payments to Acquire Property, Plant, and Equipment 590K USD +239%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -81.2M USD +39.4%
Lessee, Operating Lease, Liability, to be Paid 28.5M USD +1154%
Property, Plant and Equipment, Gross 8.38M USD +101%
Operating Lease, Liability, Current 80K USD -87.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.63M USD +164%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.02M USD +110%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +10%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.4M USD +5184%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.7M USD +3158%
Deferred Tax Assets, Operating Loss Carryforwards 33.7M USD +30.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.75M USD +20.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.78M USD
Operating Lease, Payments 780K USD 0%
Additional Paid in Capital 753M USD +31.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 880K USD +103%
Deferred Tax Assets, Net of Valuation Allowance 354K USD -51.7%
Share-based Payment Arrangement, Expense 34.8M USD +34.4%
Interest Expense 3.65M USD +42%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%